Literature DB >> 6241038

Aminoglutethimide in the treatment of advanced breast cancer.

R C Stuart-Harris, I E Smith.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6241038     DOI: 10.1016/0305-7372(84)90008-2

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN: 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  5 in total

Review 1.  Systemic therapy of advanced breast cancer.

Authors:  H T Mouridsen
Journal:  Drugs       Date:  1992       Impact factor: 9.546

2.  Aminoglutethimide-induced myelosuppression.

Authors:  J T van der Heijden; T A Splinter
Journal:  Breast Cancer Res Treat       Date:  1986       Impact factor: 4.872

3.  Long-term survival of patients given hormonal therapy for metastatic endometrial stromal sarcoma.

Authors:  J-P Spano; J-C Soria; M Kambouchner; S Piperno-Neuman; F Morin; J-F Morere; A Martin; J-L Breau
Journal:  Med Oncol       Date:  2003       Impact factor: 3.064

Review 4.  Endocrine therapy for advanced breast cancer: a review.

Authors:  H B Muss
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

5.  Therapeutic effects of the aromatase inhibitor fadrozole hydrochloride in advanced breast cancer.

Authors:  H R Bonnefoi; I E Smith; M Dowsett; P F Trunet; S J Houston; R J da Luz; R D Rubens; R C Coombes; T J Powles
Journal:  Br J Cancer       Date:  1996-02       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.